Clinical Trials Browser

Solid Tumor, Adult × Other solid neoplasm × 90 days × Clear all

NCT06977737 2026-05-22

ATTEST

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06265688 2026-05-19

First In Human Study of CX-2051 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06462794 2026-05-15

First In Human Study of CX-801 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05582850 2026-05-12

EPRAD

Phase 1 Terminated

29 enrolled 12 charts

Other solid neoplasm

Solid Tumor, Adult

NCT07159828 2026-05-06

A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor, Adult

NCT06144671 2026-04-27

GT201 Injection For The Treatment Of Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT04219254 2026-04-15

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05071846 2026-04-14

MVX-ONCO-2 in Advanced Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05223608 2026-03-30

ImmuCCo

Phase NA Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05763004 2026-03-27

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06554795 2026-03-27

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT04221204 2026-03-25

A Monotherapy in Subjects With Advanced Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT00571389 2026-03-18

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

Other solid neoplasm

Solid Tumor, Adult

NCT05689853 2026-03-18

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06391918 2026-03-13

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor, Adult

NCT04928508 2026-03-05

Okgyn1

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult